This paper is in the following e-collection/theme issue:

Non-Randomized Study Protocols and Methods (Non-eHealth) (555) HIV/AIDS/STI Prevention and Care (842) Knowledge Translation and Implementation Science (382) Public Health (172) Public Health Informatics (84) Adverse Drug Events Detection, Pharmacovigilance and Surveillance (151) Focus Groups and Qualitative Research for Human Factors Research (818) Electronic/Mobile Data Capture, Internet-based Survey & Research Methodology (808) Antimicrobial Stewardship and Antibiotic Resistance (38)

Published on in Vol 11, No 5 (2022): May

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/35969, first published .
Developing Reporting Guidelines for Studies of HIV Drug Resistance Prevalence: Protocol for a Mixed Methods Study

Developing Reporting Guidelines for Studies of HIV Drug Resistance Prevalence: Protocol for a Mixed Methods Study

Developing Reporting Guidelines for Studies of HIV Drug Resistance Prevalence: Protocol for a Mixed Methods Study

Authors of this article:

Cristian Garcia1 Author Orcid Image ;   Nadia Rehman1 Author Orcid Image ;   Daeria O Lawson1 Author Orcid Image ;   Pascal Djiadeu1 Author Orcid Image ;   Lawrence Mbuagbaw1, 2, 3, 4, 5 Author Orcid Image
Article Authors Cited by (2) Tweetations (4) Metrics

Journals

  1. Mbuagbaw L, Garcia C, Brenner B, Cecchini D, Chakroun M, Djiadeu P, Holguin A, Mor O, Parkin N, Santoro M, Ávila-Ríos S, Fokam J, Phillips A, Shafer R, Jordan M. Checklist for studies of HIV drug resistance prevalence or incidence: rationale and recommended use. The Lancet HIV 2023;10(10):e684 View
  2. Garcia C, Holbrook A, Djiadeu P, Alvarez E, Matos Silva J, Mbuagbaw L. Developing a reporting item checklist for studies of HIV drug resistance prevalence or incidence: a mixed methods study. BMJ Open 2024;14(3):e080014 View